Pinello L, Farouni R, Yuan GC. Haystack: systematic analysis of the variation of epigenetic states and cell-type specific regulatory elements. Bioinformatics. 2018;34(11):1930-1933. doi:10.1093/bioinformatics/bty031
Sheahan AV, Ellis L. Epigenetic reprogramming: A key mechanism driving therapeutic resistance. Urol Oncol. 2018;36(8):375-379. doi:10.1016/j.urolonc.2017.12.021
Hovestadt V, Ayrault O, Swartling FJ, Robinson GW, Pfister SM, Northcott PA. Medulloblastomics revisited: biological and clinical insights from thousands of patients. Nat Rev Cancer. 2020;20(1):42-56. doi:10.1038/s41568-019-0223-8
Lee JY, De Jager PL. What is the epigenome and is it involved in multiple sclerosis? Mult Scler. 2018;24(3):268-269. doi:10.1177/1352458517750769
Satpathy AT, Saligrama N, Buenrostro JD, et al. Transcript-indexed ATAC-seq for precision immune profiling. Nat Med. 2018;24(5):580-590. doi:10.1038/s41591-018-0008-8
Ma Y, De Jager PL. Designing an epigenomic study. Mult Scler. 2018;24(5):604-609. doi:10.1177/1352458517750770
Buenrostro JD, Corces R, Lareau CA, et al. Integrated Single-Cell Analysis Maps the Continuous Regulatory Landscape of Human Hematopoietic Differentiation. Cell. 2018;173(6):1535-1548.e16. doi:10.1016/j.cell.2018.03.074
Roostaei T, De Jager PL. Evaluating the role of genetic variation in the epigenome in health and disease. Mult Scler. 2018;24(6):707-709. doi:10.1177/1352458517751651
De Jager PL. Is the goal of an epigenomic study to determine causality? Mult Scler. 2018;24(7):908-909. doi:10.1177/1352458517750771
Graff M, Scott RA, Justice AE, et al. Genome-wide physical activity interactions in adiposity - A meta-analysis of 200,452 adults. PLoS Genet. 2017;13(4):e1006528. doi:10.1371/journal.pgen.1006528